Research paperAn immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome
References (24)
- et al.
Bickerstaff brain stem encephalitis: a grave non-demyelinating disease with benign prognosis
J. Neurol. Sci.
(1990) - et al.
Assessment of current diagnostic criteria for Guillain-Barré syndrome
Ann. Neurol.
(1990) - et al.
Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study
Brain
(1982) The nosological position of the ophthalmoplegia, ataxia and areflexia syndrome: “the spectrum hypothesis”
Acta. Neurol. Scand.
(1987)Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis
Br. Med. J.
(1957)Brain stem encephalitis (Bickerstaff's encephalitis)
- et al.
Mesencephalitis and rhombencephalitis
Br. Med. J.
(1951) - et al.
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
Ann. Neurol.
(1992) - et al.
Serum anti-GQ1b antibody is associated with impaired eyr movement in Miller Fisher syndrome (abstract)
Ann. Neurol.
(1992) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)
N. Engl. J. Med.
(1956)
Syndrome of Fisher: ophthalmoplegia, ataxia and areflexia
Am. J. Ophthalmol.
(1961)
Serum antibodies to gangliosides in Guillain-Barré syndrome
Ann. Neurol.
(1988)
Cited by (169)
Optic neuropathy and decorticate-like posture as presenting symptoms of Bickerstaff's brainstem encephalitis: A case report and literature review
2018, Clinical Neurology and NeurosurgeryCitation Excerpt :Although rare, patients presenting with optic neuropathy associated with these diseases have been reported in the literature [4–7]. Reports of BBE patients presenting with optic neuropathy are summarized in Table 1 [5,6]. Visual acuity can be as severely affected as hand motion as in our case.
Immunoadsorption in neurological disorders
2017, Transfusion and Apheresis ScienceCitation Excerpt :The anti-GQ1b autoantibody, which is also related to Fisher syndrome, may be detected in the serum, but the pathogenesis remains unclear [73]. The standard treatment for BBE includes IVMP, IVIG, and apheresis [74]. The ASFA guidelines did not indicate a category for apheresis in the treatment of patients with BBE.
Guillain-Barré Syndrome, variants & forms fruste: Reclassification with new criteria
2017, Clinical Neurology and NeurosurgeryA Case of Miller Fisher Syndrome with Cerebellar Hypoperfusion
2023, Tohoku Journal of Experimental Medicine
Copyright © 1993 Published by Elsevier B.V.